Michael Silverberg to Raltegravir Potassium
This is a "connection" page, showing publications Michael Silverberg has written about Raltegravir Potassium.
Connection Strength
0.219
-
Association of raltegravir use with long-term health outcomes in HIV-infected patients: an observational post-licensure safety study in a large integrated healthcare system. HIV Clin Trials. 2018 10; 19(5):177-187.
Score: 0.166
-
Associations of modern initial antiretroviral drug regimens with all-cause mortality in adults with HIV in Europe and North America: a cohort study. Lancet HIV. 2022 06; 9(6):e404-e413.
Score: 0.053